Business Description
Compare
Compare
Traded in other countries / regions
MEM.AustraliaIG7.Germany IPO Date
2007-05-14Description
Memphasys Ltd operates as a bio-separations company in Australia. It is engaged in developing and commercializing separation techniques based on the company's proprietary membrane technology. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.38 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | -2.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -3.5 | |||||
Beneish M-Score | -3.48 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -14.5 | |||||
3-Year FCF Growth Rate | 24.6 | |||||
3-Year Book Growth Rate | -6.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 21.14 | |||||
9-Day RSI | 34.84 | |||||
14-Day RSI | 41.05 | |||||
6-1 Month Momentum % | -15.79 | |||||
12-1 Month Momentum % | -78.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.49 | |||||
Days Inventory | 2352.22 | |||||
Days Sales Outstanding | 9256.81 | |||||
Days Payable | 6955.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.9 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 27.78 | |||||
Operating Margin % | -14072.22 | |||||
Net Margin % | -12927.78 | |||||
ROE % | -26.9 | |||||
ROA % | -15.63 | |||||
ROIC % | -15.85 | |||||
ROC (Joel Greenblatt) % | -66.42 | |||||
ROCE % | -19.24 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.4 | |||||
Price-to-Operating-Cash-Flow | 14 | |||||
EV-to-EBIT | -8.25 | |||||
EV-to-EBITDA | -8.76 | |||||
EV-to-Revenue | 933.5 | |||||
EV-to-FCF | -6.82 | |||||
Earnings Yield (Greenblatt) % | -12.12 |
How Memphasys Ltd (ASX:MEM) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 0.018 | ||
EPS (TTM) (A$) | -0.002 | ||
Beta | 1.41 | ||
Volatility % | 62.3 | ||
14-Day RSI | 41.05 | ||
14-Day ATR (A$) | 0.000459 | ||
20-Day SMA (A$) | 0.015 | ||
12-1 Month Momentum % | -78.5 | ||
52-Week Range (A$) | 0.012 - 0.076324 | ||
Shares Outstanding (Mil) | 959.52 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Memphasys Ltd Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |
Memphasys Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Memphasys Ltd Frequently Asked Questions
What is Memphasys Ltd(ASX:MEM)'s stock price today?
The current price of ASX:MEM is A$0.01. The 52 week high of ASX:MEM is A$0.08 and 52 week low is A$0.01.
When is next earnings date of Memphasys Ltd(ASX:MEM)?
The next earnings date of Memphasys Ltd(ASX:MEM) is .
Does Memphasys Ltd(ASX:MEM) pay dividends? If so, how much?
Memphasys Ltd(ASX:MEM) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |